Epidemiology and Prevention Unit, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.
Experimental Oncology, Center for Study of Heredo-Familial Tumors, IRCCS Istituto Tumori "Giovanni Paolo II" Bari, Bari, Italy.
Clin Breast Cancer. 2021 Jun;21(3):e168-e176. doi: 10.1016/j.clbc.2020.11.002. Epub 2020 Nov 10.
Women with deleterious mutations in BRCA1/2 have a high lifetime penetrance of developing breast cancer and/or ovarian cancer. Genetic and/or environmental factors may influence BRCA penetrance, and identifying modifiable exposures might be valuable for prevention.
We implemented a multicenter prospective 2-arm (1:1) randomized controlled trial to investigate whether a Mediterranean dietary intervention with moderate protein restriction would reduce potential modulators of BRCA penetrance such as insulin-like growth factor 1 (IGF-1), body weight, and metabolic risk factors. We studied the baseline characteristics of women with BRCA-positive disease who joined the trial cohort, focusing on the relationships between selected lifestyle exposures, metabolic/anthropometric parameters, and BRCA-related cancer.
A total of 502 women (304 with a previous diagnosis of breast cancer and/or ovarian cancer and 198 unaffected) with deleterious BRCA mutations, with or without a previous cancer, aged 18 to 70 years and without metastases were included. Late age at menarche and pregnancy were negatively associated with BRCA-related cancer, especially in women with BRCA1-positive disease. Higher fat mass and the presence of 4 or 5 metabolic risk factors were significantly associated with BRCA-related cancer (hazard ratio, 1.87, 95% confidence interval, 1.21-2.88; and hazard ratio, 1.87, 95% confidence interval, 1.11-3.19, respectively), with greater effect in BRCA2-positive women.
Our findings confirm previous observations about reproductive factors in women with BRCA disease and suggest a potential impact of metabolic factors in BRCA-related cancer. The prospective follow-up of the trial cohort will enable us to study the environmental modulators of BRCA penetrance and their impact in relation to the history of BRCA-related cancer. [ClinicalTrials.gov NCT03066856].
携带 BRCA1/2 有害突变的女性终生患乳腺癌和/或卵巢癌的风险很高。遗传和/或环境因素可能会影响 BRCA 的外显率,识别可改变的暴露因素可能对预防具有重要意义。
我们实施了一项多中心、前瞻性、2 臂(1:1)随机对照试验,以研究地中海饮食干预联合适度蛋白质限制是否会降低 BRCA 外显率的潜在调节剂,如胰岛素样生长因子 1(IGF-1)、体重和代谢危险因素。我们研究了参加试验队列的 BRCA 阳性疾病女性的基线特征,重点关注选定的生活方式暴露、代谢/人体测量参数与 BRCA 相关癌症之间的关系。
共纳入 502 名携带有害 BRCA 突变(304 名有乳腺癌和/或卵巢癌既往史,198 名无既往癌症史)、年龄 18 至 70 岁且无转移的女性。初潮和妊娠年龄较晚与 BRCA 相关癌症呈负相关,尤其是在 BRCA1 阳性疾病女性中。较高的脂肪量和存在 4 或 5 种代谢危险因素与 BRCA 相关癌症显著相关(风险比,1.87;95%置信区间,1.21-2.88;风险比,1.87;95%置信区间,1.11-3.19),BRCA2 阳性女性的影响更大。
我们的研究结果证实了先前关于 BRCA 疾病女性生殖因素的观察结果,并提示代谢因素可能对 BRCA 相关癌症有潜在影响。该试验队列的前瞻性随访将使我们能够研究 BRCA 外显率的环境调节剂及其与 BRCA 相关癌症史的关系。[ClinicalTrials.gov NCT03066856]